Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

Cancer immunotherapy: moving beyond current vaccines

Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo · Nature Medicine · 2004 · 3K citations · Full text

Medicine, Immunology, Oncology +14

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Douglas J. Schwartzentruber, David H. Lawson, Jon Richards et al. · New England Journal of Medicine · 2011 · 888 citations

Medicine, Immunology, Oncology +14

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

Edith A. Perez, Edward H. Romond, Vera J. Suman et al. · Journal of Clinical Oncology · 2011 · 718 citations · Full text

Medicine, Oncology, Pharmacology +17

Cytotoxic T-cell memory without antigen

Lisa L. Lau, Beth D. Jamieson, T. Somasundaram et al. · Nature · 1994 · 653 citations

Life Sciences, Immunology, Adaptive Immunity +11

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

Peter Brossart, Stefan Wirths, Gernot Stuhler et al. · Blood · 2000 · 540 citations

Life Sciences, Cell Biology, Immunology +14